177 related articles for article (PubMed ID: 35337852)
1. Nanog, as a key cancer stem cell marker in tumor progression.
Vasefifar P; Motafakkerazad R; Maleki LA; Najafi S; Ghrobaninezhad F; Najafzadeh B; Alemohammad H; Amini M; Baghbanzadeh A; Baradaran B
Gene; 2022 Jun; 827():146448. PubMed ID: 35337852
[TBL] [Abstract][Full Text] [Related]
2. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.
Alemohammad H; Asadzadeh Z; Motafakker Azad R; Hemmat N; Najafzadeh B; Vasefifar P; Najafi S; Baradaran B
Life Sci; 2020 Nov; 260():118337. PubMed ID: 32841661
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
[TBL] [Abstract][Full Text] [Related]
4. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
5. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
6. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.
Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR
Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909
[TBL] [Abstract][Full Text] [Related]
7. Insights into the
Zhang W; Sui Y; Ni J; Yang T
Int J Biol Sci; 2016; 12(11):1372-1381. PubMed ID: 27877089
[TBL] [Abstract][Full Text] [Related]
8. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
10. RNAi mediated silencing of Nanog expression suppresses the growth of human colorectal cancer stem cells.
Zhang C; Zhao Y; Yang Y; Zhong C; Ji T; Duan J; Wang Y
Biochem Biophys Res Commun; 2021 Jan; 534():254-260. PubMed ID: 33288197
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin induces stemness in ovarian cancer.
Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
[TBL] [Abstract][Full Text] [Related]
13. The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers.
Fatma H; Siddique HR; Maurya SK
Epigenomics; 2021 Dec; 13(23):1885-1900. PubMed ID: 34693722
[TBL] [Abstract][Full Text] [Related]
14.
Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
[TBL] [Abstract][Full Text] [Related]
15. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
16. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
17. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
Yao C; Su L; Shan J; Zhu C; Liu L; Liu C; Xu Y; Yang Z; Bian X; Shao J; Li J; Lai M; Shen J; Qian C
Stem Cells; 2016 Apr; 34(4):820-31. PubMed ID: 26840943
[TBL] [Abstract][Full Text] [Related]
18. Identification and Isolation of Cancer Stem Cells Using NANOG-EGFP Reporter System.
Buczek ME; Reeder SP; Regad T
Methods Mol Biol; 2018; 1692():139-148. PubMed ID: 28986894
[TBL] [Abstract][Full Text] [Related]
19. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Narusaka T; Ohara T; Noma K; Nishiwaki N; Katsura Y; Kato T; Sato H; Tomono Y; Kikuchi S; Tazawa H; Shirakawa Y; Matsukawa A; Fujiwara T
Int J Cancer; 2021 Jul; 149(2):347-357. PubMed ID: 33662150
[TBL] [Abstract][Full Text] [Related]
20. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]